Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Other Working Capital Changes (2016 - 2025)

Neuroone Medical Technologies' Other Working Capital Changes history spans 8 years, with the latest figure at $13155.0 for Q4 2025.

  • For Q4 2025, Other Working Capital Changes rose 160.45% year-over-year to $13155.0; the TTM value through Dec 2025 reached -$40172.0, down 152.0%, while the annual FY2025 figure was -$75089.0, 58.8% down from the prior year.
  • Other Working Capital Changes reached $13155.0 in Q4 2025 per NMTC's latest filing, up from -$91991.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $1.5 million in Q1 2023 to a low of -$1.5 million in Q4 2022.
  • Average Other Working Capital Changes over 5 years is $74482.2, with a median of -$1851.0 recorded in 2022.
  • Peak YoY movement for Other Working Capital Changes: crashed 10561.5% in 2022, then soared 66719.23% in 2023.
  • A 5-year view of Other Working Capital Changes shows it stood at -$13649.0 in 2021, then plummeted by 10561.5% to -$1.5 million in 2022, then soared by 99.74% to -$3780.0 in 2023, then plummeted by 475.71% to -$21762.0 in 2024, then soared by 160.45% to $13155.0 in 2025.
  • Per Business Quant, the three most recent readings for NMTC's Other Working Capital Changes are $13155.0 (Q4 2025), -$91991.0 (Q3 2025), and $25296.0 (Q2 2025).